132 related articles for article (PubMed ID: 3694002)
1. [Clinical efficacy of interferon-beta (MR-21) in hematological malignancies].
Imamura Y
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):934-41. PubMed ID: 3694002
[No Abstract] [Full Text] [Related]
2. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
Ohno R; Kodera Y; Ogura M; Murase T; Emi N; Okumura M; Morishita Y; Nagura E; Minami S; Morishima Y
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2531-6. PubMed ID: 6594973
[TBL] [Abstract][Full Text] [Related]
4. INTRON A (interferon alfa-2b): clinical overview.
Spiegel RJ
Cancer Treat Rev; 1985 Dec; 12 Suppl B():5-16. PubMed ID: 3914355
[No Abstract] [Full Text] [Related]
5. [Clinical study on the effect of human lymphoblastoid interferon in B-cell malignancies].
Takeyama H; Yano K; Kataoka T; Watanabe E; Kobayashi M; Ohno R
Rinsho Ketsueki; 1984 Dec; 25(12):1921-7. PubMed ID: 6442741
[No Abstract] [Full Text] [Related]
6. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of rDNA human alpha-2 interferon in multiple myeloma.
Wagstaff J; Loynds P; Scarffe JH
Cancer Treat Rep; 1985 May; 69(5):495-8. PubMed ID: 4005872
[TBL] [Abstract][Full Text] [Related]
8. [Interferon-alpha in the treatment of hematologic neoplasms].
Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C
Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022
[TBL] [Abstract][Full Text] [Related]
9. Treatment of multiple myeloma with recombinant human leukocyte A interferon.
Ohno R; Kimura K; Amaki I; Imamura Y; Masaoka T; Miyazaki T; Yoshida Y; Miura Y; Maekawa T; Oguro M
Cancer Treat Rep; 1985 Dec; 69(12):1433-5. PubMed ID: 4075317
[TBL] [Abstract][Full Text] [Related]
10. [Clinical effects of human lymphoblastoid interferon in patients with hematologic neoplasms].
Oda Y; Irie S; Inagaki M; Fukumoto M; Ueda I; Ohmoto E; Fujimoto S; Endo Y; Watanabe S; Lai M; Takahashi I; Kimura I; Ishii H; Sezaki T
Gan To Kagaku Ryoho; 1983 May; 10(5):1313-9. PubMed ID: 6575725
[TBL] [Abstract][Full Text] [Related]
11. [Effects of interferon on various malignancies].
Taguchi T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and immunological studies of human fibroblast interferon and human lymphoblastoid interferon in malignant diseases].
Ezaki K
Gan No Rinsho; 1983 May; 29(6):598-602. PubMed ID: 6308306
[No Abstract] [Full Text] [Related]
13. Phase II study of human lymphoblastoid interferon in patients with multiple myeloma.
Cox EB; Laszlo J; Krown S; Mintzer D; Sarna G
J Biol Response Mod; 1988 Jun; 7(3):318-25. PubMed ID: 3392554
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy of interferon-beta (MR-21) in renal cell carcinoma and cancer of the bladder].
Niijima T
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):928-33. PubMed ID: 3694001
[No Abstract] [Full Text] [Related]
15. Interferon-alpha: current status and future promise.
Bonnem EM; Spiegel RJ
J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
[No Abstract] [Full Text] [Related]
16. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
Kimura K
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
[TBL] [Abstract][Full Text] [Related]
17. [Phase II study of interferon-beta (MR-21) in solid tumors. The Cooperative Study Group of MR-21 in Tumor].
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):942-7. PubMed ID: 3694003
[No Abstract] [Full Text] [Related]
18. [Interferons in cancerology. Focus in 1988].
Boiron M
Pathol Biol (Paris); 1989 Feb; 37(2):92-3. PubMed ID: 2652080
[No Abstract] [Full Text] [Related]
19. Clinical uses for interferon in the treatment of cancer. A critical review.
Ringenberg QS; Patterson WP
Mo Med; 1988 Jan; 85(1):21-6. PubMed ID: 3277031
[No Abstract] [Full Text] [Related]
20. Interferons and cancer therapy.
Priestman TJ
J Pathol; 1983 Nov; 141(3):287-95. PubMed ID: 6363649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]